TrialDrug design, development and therapy2011

Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial.

James P Simsarian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.